Institut Gustave-Roussy, France
Bernard Escudier, MD
Genitourinary Group
Gustave Roussy, Villejuif, France
Bernard Escudier, MD, is the former chair of the genitourinary group of the Institut Gustave Roussy in Villejuif, France. Dr. Escudier’s research focuses on renal cell carcinoma, immunotherapy and on development of new therapeutic strategies.
Dr. Escudier received his medical degree from the University of Paris, Paris, France, and initially trained as a cardiologist and then an intensivist. He became the head of the first immunotherapy unit in Gustave Roussy in 1992, and then moved to the Medical Oncology Department.
He has authored more than 500 publications in peer-reviewed journals and is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the European Society for Medical Oncology. He is also a member of the board of the Kidney Cancer Association and president of ARTuR (the French association on renal tumors). Dr. Escudier has been the head of the French Group of Immunotherapy from 1992 to 2012, which conducts large multicenter phase 2/3 studies in renal cancer; he is also a principal investigator for many phase 1 to 3 clinical trials in renal cancer. He has been part of the development of every new agent from cytokines to VEGF/mTOR taregted agents and more recently new immunotherapy.
Dr. Escudier was head of the ESMO GU faculty from 2012 to 2014 and has been the coordinator of the RCC ESMO guideline group since 2012.